Intracardiac echocardiography in electrophysiology.

Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol (2008) 1.18

Intracardiac Echocardiography during Catheter-Based Ablation of Atrial Fibrillation. Cardiol Res Pract (2012) 0.84

3D and 4D echo--applications in EP laboratory procedures. J Interv Card Electrophysiol (2008) 0.76

[Ultrasound in the electrophysiological cardiac catheterization laboratory]. Herzschrittmacherther Elektrophysiol (2012) 0.75

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22

A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 7.26

Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation (2000) 6.56

Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation (2004) 3.69

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace (2006) 3.52

Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation (2000) 3.43

Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation (2003) 2.18

Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. Eur Heart J (1998) 1.63

Radiofrequency catheter ablation of idiopathic left ventricular outflow tract tachycardia: utility of intracardiac echocardiography. J Cardiovasc Electrophysiol (2001) 1.57

Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol (2004) 1.31

The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn (1994) 1.26

Multislice computed tomography versus intracardiac echocardiography to evaluate the pulmonary veins before radiofrequency catheter ablation of atrial fibrillation: a head-to-head comparison. J Am Coll Cardiol (2005) 1.26

Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr (2004) 1.25

Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol (2005) 1.15

Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol (1999) 1.11

Intracardiac echocardiography (9 MHz) in humans: methods, imaging views and clinical utility. Ultrasound Med Biol (1999) 1.05

Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2002) 0.91

Microbubbles during radiofrequency catheter ablation: composition and formation. Heart Rhythm (2005) 0.89

Phased-array intracardiac echocardiography during pulmonary vein isolation and linear ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2002) 0.89

Magnetic resonance angiography of pulmonary veins: implications for catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol (2005) 0.88

Phased-array intracardiac echocardiography for defining cavotricuspid isthmus anatomy during radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol (2003) 0.83

Embolic complications after radiofrequency catheter ablation. Am J Cardiol (1994) 0.83

Usefulness of intracardiac echocardiography in transseptal puncture during percutaneous transvenous mitral commissurotomy. Am J Cardiol (1993) 0.82

Use of intracardiac echocardiography in guiding radiofrequency catheter ablation of atrial tachycardia in a patient after the senning operation. Pacing Clin Electrophysiol (2003) 0.77

The "pop phenomenon" detected by phased array intracardiac echocardiography. Heart (2003) 0.75

Complications in transseptal left heart catheterization. Acta Med Scand (1966) 0.75

CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48

Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22

Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. J Virol (1995) 1.96

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J Virol (1995) 1.44

Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med (1997) 1.31

Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25

New insights into mechanisms of atrial fibrillation. Physiol Res (2009) 0.98

In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol (1994) 0.96

Biochemical markers in menopausal women. Scand J Clin Lab Invest Suppl (1997) 0.84

SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety. Antimicrob Agents Chemother (1995) 0.79

HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization. Antiviral Res (1994) 0.77

[Hypersensitivity vasculitis causing an acute abdomen]. Wien Klin Wochenschr (1999) 0.77

NAP-1/IL-8 in rheumatoid arthritis. Adv Exp Med Biol (1991) 0.76

Effect of sodium monofluorophosphate and calcium on bone density and fracture rate in osteoporosis. Lancet (1990) 0.75

Mucosal IgA is an important moderator of eosinophil responses to tissue-derived chemoattractants. Int Arch Allergy Immunol (1995) 0.75

Prognostic factors for the outcome of methotrexate treatment in rheumatoid arthritis. Clin Rheumatol (1995) 0.75

[The effect of HLA-DRB4 on the clinical picture of chronic polyarthritis]. Z Rheumatol (1989) 0.75

Successful ablation of ventricular tachycardia after correction of tetralogy of Fallot. Herzschrittmacherther Elektrophysiol (2014) 0.75

Autoantibodies associated with rheumatic diseases. Clin Chem Lab Med (2001) 0.75

[Medical expert and consultation systems: review and examples for their use]. Acta Med Austriaca (1987) 0.75

Gastric mucosal interleukin-8 and IL-8 antibody concentrations related to prevailing Helicobacter pylori infections. A Danish-Albanian study. Dan Med Bull (1999) 0.75